Significance of Supraventricular Tachyarrhythmias After Coronary Artery Bypass Graft Surgery and Their Prevention by Low-Dose Sotalol: A Prospective Double-Blind Randomized Placebo-Controlled Study

Background: The single most frequent complication after coronary artery bypass graft surgery is the occurrence of supraventricular tachyarrhythmias leading to a prolonged hospital stay. Although several drugs have been used to treat these arrhythmias, effective prevention was only possible with beta-blocking drugs in selected patients. It was, therefore, the aim of the present study to evaluate the significance of supraventricular tachyarrhythmias in presence of today's cardioprotective management in a broad spectrum of patients and to assess the possible preventive effect and safety of low-dose sotalol after coronary artery bypass graft surgery. Methods and Results: In a prospective randomized double-blind placebo-controlled trial, 220 consecutive patients referred for elective coronary artery bypass graft surgery were random ized to 80 mg sotalol twice daily (n = 110) or matching placebo (n = 110) for 3 months with the first dose given 2 hours before surgery. There were no significant differences in baseline charac teristics between the two groups. Low-dose sotalol reduced the rate of supraventricular arrhythmias from 43% (placebo) to 25% (sotalol, P <.01), which was atrial fibrillation in 83%, flutter in 7%, and other supraventricular arrhythmias in 10%. Only 7% of all arrhythmias were observed after day 9. Hospital stay was I 1 ± 4 days in patients with supraventricular arrhyth mias versus 9 ± 2 days (P < .001) in patients without. On the fourth postoperative day, heart rate was lower in the sotalol group (75 ± 12 versus 86 ± 14 beats per min; P < .0001), but QTc was not significantly prolonged (sotalol, 0.44 ± 0.03; placebo 0.43 ± 0.03; P. ns). Study medica tion had to be discontinued due to side effects in 6.4% of sotalol and 3.6% of placebo patients (P. ns), but relevant side effects occurred only in two sotalol patients late after surgery. Conclusions: These data show that without antiarrhythmic therapy the incidence of supraventricular arrhythmias after coronary artery bypass graft surgery is high (43%) and that supraventricular arrhythmias were associated with a prolonged hospital stay (+2 days). Prophylactic treatment with low-dose sotalol reduced the incidence of supraventricular arrhythmias significantly (by 40%), thereby reducing overall hospital stay in treated patients. Because more than 90% of all supraventricular arrhythmic episodes occurred within 10 days after surgery and considering the small proarrhythmic effect of sotalol late after surgery, prophylactic treatment with sotalol may be recommended for the first 10 postoperative days to safely reduce supraventricular tachyarrhythmias.

[1]  F. Morady,et al.  Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery. , 1998, The New England journal of medicine.

[2]  Bertram Pitt,et al.  Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction , 1996, The Lancet.

[3]  A M Tonkin,et al.  Atrial fibrillation after coronary artery bypass grafting is associated with sympathetic activation. , 1995, The Annals of thoracic surgery.

[4]  R. Dion,et al.  Hemodynamic effects and safety of sotalol in the prevention of supraventricular arrhythmias after coronary artery bypass surgery. , 1994, Journal of cardiothoracic and vascular anesthesia.

[5]  J L Cox,et al.  Hazards of postoperative atrial arrhythmias. , 1994, The Annals of thoracic surgery.

[6]  M. Demirtaş,et al.  Is continuous normothermic blood cardioplegia really a practical way of myocardial preservation? Comparison with intermittent cold crystalloid cardioplegia. , 1993, The Thoracic and cardiovascular surgeon.

[7]  G. Laub,et al.  Prophylactic procainamide for prevention of atrial fibrillation after coronary artery bypass grafting: A prospective, double‐blind, randomized, placebo‐controlled pilot study , 1993, Critical care medicine.

[8]  S. Westaby,et al.  Amiodarone prophylaxis for tachycardias after coronary artery surgery: a randomised, double blind, placebo controlled trial. , 1993, British heart journal.

[9]  K. Rådegran,et al.  Oral Sotalol Reduces the Incidence of Atrial Fibrillation after Coronary Artery Bypass Surgery , 1993, The Thoracic and cardiovascular surgeon.

[10]  M. England,et al.  Magnesium administration and dysrhythmias after cardiac surgery. A placebo-controlled, double-blind, randomized trial. , 1992, JAMA.

[11]  H. Mølgaard,et al.  Atrial fibrillation and flutter after coronary artery bypass surgery: epidemiology, risk factors and preventive trials. , 1992, International journal of cardiology.

[12]  R. Falk Proarrhythmia in Patients Treated for Atrial Fibrillation or Flutter , 1992, Annals of Internal Medicine.

[13]  L. Bianconi,et al.  Efficacy of intravenous propafenone in acute atrial fibrillation complicating open-heart surgery. , 1992, American heart journal.

[14]  J. Tijssen,et al.  Effectiveness of sotalol in preventing supraventricular tachyarrhythmias shortly after coronary artery bypass grafting. , 1991, The American journal of cardiology.

[15]  R. Hall,et al.  Atrial tachyarrhythmias after cardiac surgery. , 1991, European heart journal.

[16]  S. Hohnloser,et al.  Electrocardiographic and antiarrhythmic effects of intravenous amiodarone: results of a prospective, placebo-controlled study. , 1991, American heart journal.

[17]  J A Burkholder,et al.  Risk factors for atrial fibrillation after coronary artery bypass grafting. , 1990, The American journal of cardiology.

[18]  S. Juul-Möller,et al.  Sotalol versus quinidine for the maintenance of sinus rhythm after direct current conversion of atrial fibrillation. , 1990 .

[19]  R. M. Tjon Joe Gin,et al.  Efficacy and safety of low- and high-dose sotalol versus propranolol in the prevention of supraventricular tachyarrhythmias early after coronary artery bypass operations. , 1990, The Journal of thoracic and cardiovascular surgery.

[20]  A. Camm,et al.  Efficacy of flecainide acetate for atrial arrhythmias following coronary artery bypass grafting. , 1989, The American journal of cardiology.

[21]  M. Lauer,et al.  Atrial fibrillation following coronary artery bypass surgery. , 1989, Progress in cardiovascular diseases.

[22]  A. Lolk,et al.  Supraventricular Tachyarrhythmias After Coronary Bypass Surgery - A Double Blind Randomized Trial of Prophylactic Low Dose Propranolol , 1988, The Thoracic and cardiovascular surgeon.

[23]  G. Prabhakar,et al.  The use of atenolol in the prevention of supraventricular arrhythmias following coronary artery surgery. , 1988, European heart journal.

[24]  C. Cabrol,et al.  Prevention of atrial fibrillation or flutter by acebutolol after coronary bypass grafting. , 1986, The American journal of cardiology.

[25]  M. Taams,et al.  Prevention and Treatment of Supraventricular Tachycardia Shortly After Coronary Artery Bypass Grafting: A Randomized Open Trial , 1986, Angiology.

[26]  E. L. Decker,et al.  Digoxin prophylaxis following coronary artery bypass surgery. , 1986, Clinical pharmacy.

[27]  S. Lemeshow,et al.  Does the type of venous drainage or cardioplegia affect postoperative conduction and atrial arrhythmias? , 1985, Circulation.

[28]  M. Parker,et al.  Prophylaxis of supraventricular tachyarrhythmia after coronary bypass surgery with oral verapamil: a randomized, double-blind trial. , 1985, The Annals of thoracic surgery.

[29]  E. Antman,et al.  Efficacy and safety of timolol for prevention of supraventricular tachyarrhythmias after coronary artery bypass surgery. , 1984, Circulation.

[30]  Effects of low dose propranolol after coronary bypass surgery. , 1984, The Journal of cardiovascular surgery.

[31]  M. Petch,et al.  Arrhythmias after coronary bypass surgery. , 1984, British heart journal.

[32]  R. Eich,et al.  Supraventricular arrhythmias following coronary artery bypass. The effect of preoperative digitalis. , 1983, The Journal of thoracic and cardiovascular surgery.

[33]  M. Bassan,et al.  Clinical course of acute atrial fibrillation treated with rapid digitalization. , 1983, American heart journal.

[34]  R. D. King,et al.  Immediate postoperative digitalization in the prophylaxis of supraventricular arrhythmias following coronary artery bypass. , 1981, The Journal of thoracic and cardiovascular surgery.

[35]  M. Josephson,et al.  Propranolol for prevention of postoperative cardiac arrhythmias: a randomized study. , 1980, The Annals of thoracic surgery.